Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario P Colombo

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|March 19, 2021
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to AdenocarcinomaRoberta Sulsenti, Barbara Frossi, Lucia Bongiovanni, et al.
Growth Factors (Chur, Switzerland)|January 21, 2014
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cellsClara Contaldo, Timothy J Myers, Cinzia Zucchini, et al.
Cancer Research|February 21, 2006
Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinomaIñigo Tirapu, Eduardo Huarte, Cristiana Guiducci, et al.
The Journal of Experimental Medicine|August 21, 2002
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibodyAlain P Vicari, Claudia Chiodoni, Céline Vaure, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2005
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccinationCarmela De Santo, Paolo Serafini, Ilaria Marigo, et al.
The Journal of Clinical Investigation|March 4, 2010
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesisAnna Rocchi, Maria Cristina Manara, Marika Sciandra, et al.
Cancer Research|November 29, 2019
Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAsClaudia Chiodoni, Valeria Cancila, Tiziana A Renzi, et al.
Frontiers in Immunology|July 9, 2019
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive ActivitiesSabina Sangaletti, Giovanna Talarico, Claudia Chiodoni, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2012
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancerMichele Maio, Hugues J M Nicolay, Paolo A Ascierto, et al.
Cell Reports|September 24, 2013
IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditionsIvan Zanoni, Roberto Spreafico, Caterina Bodio, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|March 19, 2021
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to AdenocarcinomaRoberta Sulsenti, Barbara Frossi, Lucia Bongiovanni, et al.
Growth Factors (Chur, Switzerland)|January 21, 2014
Expression levels of insulin receptor substrate-1 modulate the osteoblastic differentiation of mesenchymal stem cells and osteosarcoma cellsClara Contaldo, Timothy J Myers, Cinzia Zucchini, et al.
Cancer Research|February 21, 2006
Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinomaIñigo Tirapu, Eduardo Huarte, Cristiana Guiducci, et al.
The Journal of Experimental Medicine|August 21, 2002
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibodyAlain P Vicari, Claudia Chiodoni, Céline Vaure, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 9, 2005
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccinationCarmela De Santo, Paolo Serafini, Ilaria Marigo, et al.
The Journal of Clinical Investigation|March 4, 2010
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesisAnna Rocchi, Maria Cristina Manara, Marika Sciandra, et al.
Cancer Research|November 29, 2019
Transcriptional Profiles and Stromal Changes Reveal Bone Marrow Adaptation to Early Breast Cancer in Association with Deregulated Circulating microRNAsClaudia Chiodoni, Valeria Cancila, Tiziana A Renzi, et al.
Frontiers in Immunology|July 9, 2019
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive ActivitiesSabina Sangaletti, Giovanna Talarico, Claudia Chiodoni, et al.
Cancer Immunology, Immunotherapy : CII|June 28, 2012
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancerMichele Maio, Hugues J M Nicolay, Paolo A Ascierto, et al.
Cell Reports|September 24, 2013
IL-15 cis presentation is required for optimal NK cell activation in lipopolysaccharide-mediated inflammatory conditionsIvan Zanoni, Roberto Spreafico, Caterina Bodio, et al.
Pageof 15